William Blair Reiterates Outperform Rating on Abbvie (ABBV): "competitive across the amylin class"
Go back to William Blair Reiterates Outperform Rating on Abbvie (ABBV): "competitive across the amylin class"| AbbVie (NYSE: ABBV) | Delayed: 251.06 -0.58 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $251.64 | 52 Week High | $68.12 | |||
| Open | $250.75 | 52 Week Low | $50.71 | |||
| Day High | $251.80 | P/E | 54.46 | |||
| Day Low | $247.56 | EPS | $4.61 | |||
| Volume | 6,987,823 | |||||
